Home > Research > Publications & Outputs > Personalized medicine in context

Associated organisational unit

View graph of relations

Personalized medicine in context: social science perspectives

Research output: Contribution to Journal/MagazineJournal articlepeer-review

<mark>Journal publication date</mark>2013
<mark>Journal</mark>Drug Discovery Today: Therapeutic Strategies
Issue number4
Number of pages5
Pages (from-to)e183-e187
Publication StatusPublished
Early online date11/07/13
<mark>Original language</mark>English


In the 1990s, the scientific and popular press heralded the emergence of a new paradigm in drug discovery and development called pharmacogenomics (pgmx). As well as capturing the interest of scientists, policymakers and journalists, the field of personalized medicine has also been of immense interest to social scientists who research new innovations in health and biomedicine. This article reviews existing social science research on pgmx. It considers work on mapping industry involvement in pgmx; the dynamics of clinical adoption and the challenges of pgmx testing becoming a standard healthcare service; and patient and public perspectives on pgmx. In conclusion, the article reflects on the future research agenda.